Middle Meningeal Artery Embolization Combined With Endoscopic Treatment for Chronic Subdural Hematoma

J Craniofac Surg. 2023 Nov-Dec;34(8):2529-2532. doi: 10.1097/SCS.0000000000009715. Epub 2023 Sep 4.

Abstract

Objective: To explore the clinical feasibility of middle meningeal artery (MMA) embolization combined with endoscopic treatment for new or recurrent chronic subdural hematoma (CSDH).

Methods: Twenty patients with CSDH treated in the Binzhou Medical University Hospital from June 2020 to October 2022 were analyzed retrospectively. The clinical information, prognosis, imaging results, and surgical results of the patients were collected and analyzed. The authors first performed MMA embolization, and then endoscopic treatment of CSDH was performed after successful embolization of MMA. Results: All 20 patients with CSDH were successfully treated with MMA embolization combined with endoscope-assisted evacuation. The symptoms of all patients were relieved, no surgical complications occurred, and no rebleeding and recurrence were found in follow-up computed tomography.

Conclusion: Middle meningeal artery embolization combined with endoscopic treatment of CSDH has a good clinical effect, and it may prevent postoperative recurrence.

MeSH terms

  • Embolization, Therapeutic* / methods
  • Hematoma, Subdural, Chronic* / diagnostic imaging
  • Hematoma, Subdural, Chronic* / surgery
  • Humans
  • Meningeal Arteries / diagnostic imaging
  • Meningeal Arteries / surgery
  • Retrospective Studies
  • Treatment Outcome